Positive Trial Results For BioDelivery
BioDelivery Sciences International Inc. (BDSI) reported positive trial results for its pain reducing drug in cancer patients sending the stock price soaring $1.41 to close at $6.05.
posted by FC Market News at 8:45 AM
0 Comments:
Post a Comment
<< Home